Cosm Medical partners with Duke Health and Mayo Clinic for 3D-printed post-surgery gynecological devices

Cosm Medical, a Canadian medtech company, has entered a licensing and collaboration agreement with Duke Health and the Mayo Clinic to develop Gynethotics Recovery, a product line of personalized intravaginal devices for postoperative recovery after reconstructive pelvic surgery. The company’s digital platform combines medical imaging with 3D printing to produce biocompatible, patient-specific supports, aiming to improve fit and comfort over standard pessaries. The partnership includes intellectual property licensing, product evaluation, clinical validation, and potential commercialization.

This deal extends the medical-dental vertical’s personalization logic into gynecology, a field where additive manufacturing has been slower to penetrate compared to orthopedics or dental aligners. Cosm Medical’s approach mirrors the patient-specific paradigm that Align Technology (Invisalign) scaled in orthodontics, but applied to a surgical recovery context with higher anatomical variability and less standardized device geometry. The collaboration brings academic clinical expertise from two top-tier U.S. medical centers, which is critical for generating the evidence base needed to shift from one-size-fits-all postoperative care to a personalized standard. The lack of validated, anatomically customized post-surgical supports in pelvic floor reconstruction represents a clear clinical gap that AM can address, provided the materials and design prove safe and effective in a regulatory pathway.

The immediate challenge for Cosm Medical is demonstrating reproducible clinical outcomes across a patient population with diverse anatomy and healing profiles. The company must execute rigorous usability studies and regulatory submissions (likely FDA 510(k) or De Novo) before Gynethotics Recovery reaches broader clinical use. For now, this partnership validates that leading institutions see additive manufacturing as a viable route to precision in a historically underserved area of women's health.